Literature DB >> 6986407

Serodiagnosis of respiratory synctial virus infections in infants and young children by the immunoperoxidse technique.

G Gerna, E Cattaneo, P M Cereda, M Grazia Revello, G Achilli.   

Abstract

The immunoperoxidase antibody (IPA) technique was used to develop two new tests for serodiagnosis of respiratory syncytial virus infections: a microneutralization test based on the reduction of the number of infected cells and an IPA test for determination of virus-specific immunoglobulin G (IgG). Neutralizing antibody was determined both in the presence and absence of complement. In a group of 24 infants and young childres, ages less than 1 to 36 months, with acute respiratory syncytial virus infection, serodiagnosis was made by the IPA-IgG test in 20 cases, by neutralization test with addition of complement in 19 cases, and by neutralization test without addition of complement in 17 cases. Complement fixation detected only 12 cases of infection. All four cases not serologically diagnosed were infants less than 1 month old. Neutralization test antibody titers in the presence of complement were usually 4- to 16-fold higher than titers obtained without addition of complement. Both IPA-IgG and neutralization test (in the presence of complement) appear very efficient in serologically detecting respiratory syncytial virus infections in infants older than 1 month and give rapid results (IPA-IgG takes 2 h to complete, and the neutralization test takes 24 h). However, IPA-IgG is simpler to perform.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6986407      PMCID: PMC273321          DOI: 10.1128/jcm.11.1.79-87.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children.

Authors:  R M CHANOCK; H W KIM; A J VARGOSKO; A DELEVA; K M JOHNSON; C CUMMING; R H PARROTT
Journal:  JAMA       Date:  1961-05-27       Impact factor: 56.272

2.  Determination of neutralizing antibody and IgG antibody to varicella-zoster virus and of IgG antibody to membrane antigens by the immunoperoxidase technique.

Authors:  G Gerna; G Achilli; R W Chambers
Journal:  J Infect Dis       Date:  1977-06       Impact factor: 5.226

3.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

Authors:  R H Parrott; H W Kim; J O Arrobio; D S Hodes; B R Murphy; C D Brandt; E Camargo; R M Chanock
Journal:  Am J Epidemiol       Date:  1973-10       Impact factor: 4.897

4.  Further investigations of live respiratory syncytial virus vaccine administered parenterally.

Authors:  E B Buynak; R E Weibel; A J Carlson; A A McLean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-02

5.  Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.

Authors:  J Mills; J E Van Kirk; P F Wright; R M Chanock
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

6.  Pathogenesis of respiratory syncytial virus diseases in infancy.

Authors:  C A Ross; I W Pinkerton; F A Assaad
Journal:  Arch Dis Child       Date:  1971-10       Impact factor: 3.791

7.  Immunoperoxidase technique for detection of antibodies to human cytomegalovirus.

Authors:  G Gerna; C J McCloud; R W Chambers
Journal:  J Clin Microbiol       Date:  1976-03       Impact factor: 5.948

8.  Immunofluorescence for routine diagnosis of respiratory syncytial virus infection.

Authors:  G E Urquhart; G H Walker
Journal:  J Clin Pathol       Date:  1972-10       Impact factor: 3.411

9.  Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection.

Authors:  L S Richardson; R H Yolken; R B Belshe; E Camargo; H W Kim; R M Chanock
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

10.  Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus.

Authors:  H W Kim; J O Arrobio; G Pyles; C D Brandt; E Camargo; R M Chanock; R H Parrott
Journal:  Pediatrics       Date:  1971-11       Impact factor: 7.124

View more
  4 in total

Review 1.  Detection, pathogenesis, and therapy of respiratory syncytial virus infections.

Authors:  R C Welliver
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

2.  Production of antiserum to respiratory syncytial virus polypeptides: application in enzyme-linked immunosorbent assay.

Authors:  A Hornsleth; P C Grauballe; B Friis; J Genner; I R Pedersen
Journal:  J Clin Microbiol       Date:  1981-11       Impact factor: 5.948

3.  Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement.

Authors:  A L Frank; J Puck; B J Hughes; T R Cate
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

4.  Prevalence of antibody to human coronaviruses 229E, OC43 and neonatal calf diarrhea coronavirus (NCDCV) in patients of Northern Italy.

Authors:  P M Cereda; L Pagani; E Romero
Journal:  Eur J Epidemiol       Date:  1986-06       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.